CELZ — Creative Medical Technology Holdings Balance Sheet
0.000.00%
- $5.55m
- $0.17m
- $0.01m
- 35
- 20
- 82
- 42
Annual balance sheet for Creative Medical Technology Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 0.098 | 10.7 | 18.4 | 9.99 | 5.94 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0 | 0.002 | 0 | — | — |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 0.098 | 10.7 | 18.7 | 10.3 | 6.14 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 0.718 | 11.3 | 19.2 | 10.7 | 6.67 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 40.5 | 1.05 | 3.32 | 0.371 | 0.328 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 40.5 | 1.05 | 3.32 | 0.371 | 0.328 |
| Redeemable Preferred Stock | |||||
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Total Equity | -39.8 | 10.2 | 15.9 | 10.3 | 6.34 |
| Total Liabilities & Shareholders' Equity | 0.718 | 11.3 | 19.2 | 10.7 | 6.67 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |